Calton & Associates’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,971
Closed -$193K 346
2019
Q2
$193K Sell
10,971
-512
-4% -$9.03K 0.05% 269
2019
Q1
$207K Buy
+11,483
New +$202K 0.06% 239
2018
Q3
Sell
-13,420
Closed -$258K 294
2018
Q2
$258K Buy
+13,420
New +$252K 0.08% 219
2018
Q1
Sell
-3,141
Closed -$60K 553
2017
Q4
$60K Buy
+3,141
New +$56.1K 0.02% 627

Other funds holding DIAX

Calton & Associates's DIAX Position: Q3 2019 in Review

Calton & Associates sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q3 2019, closing a stake of 10,971 shares — an estimated $193K sold.

Calton & Associates first reported a position in DIAX in Q4 2017 and held it in 4 quarters. The position peaked at $258K in Q2 2018. 74 funds tracked by Wall St. Rank hold DIAX as of Q3 2019.

  • Calton & Associates reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q3 2019 after selling out during the quarter.
  • Calton & Associates sold 10,971 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2019, an estimated $193K.
  • Calton & Associates first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2017 and held it in 4 quarters.
  • Calton & Associates's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $258K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2019.

Based on Calton & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.